Report Detail

Pharma & Healthcare Global Respiratory Drug Market Insights, Forecast to 2025

  • RnM2455924
  • |
  • 16 May, 2019
  • |
  • Global
  • |
  • 127 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Respiratory Drug Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Respiratory Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Respiratory Drug Market Size Growth Rate by Product
      • 1.4.2 Advair
      • 1.4.3 Symbicort turbuhaler
      • 1.4.4 Spiriva
      • 1.4.5 Xolair
      • 1.4.6 Ventolin
      • 1.4.7 Pulmicort
      • 1.4.8 Orkambi
      • 1.4.9 Relvar/breo ellipta
      • 1.4.10 Singulair
      • 1.4.11 Esbriet
    • 1.5 Market by End User
      • 1.5.1 Global Respiratory Drug Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Home care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Respiratory Drug Market Size
      • 2.1.1 Global Respiratory Drug Revenue 2014-2025
      • 2.1.2 Global Respiratory Drug Sales 2014-2025
    • 2.2 Respiratory Drug Growth Rate by Regions
      • 2.2.1 Global Respiratory Drug Sales by Regions
      • 2.2.2 Global Respiratory Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Respiratory Drug Sales by Manufacturers
      • 3.1.1 Respiratory Drug Sales by Manufacturers
      • 3.1.2 Respiratory Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Respiratory Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Respiratory Drug Revenue by Manufacturers
      • 3.2.1 Respiratory Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Respiratory Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Respiratory Drug Price by Manufacturers
    • 3.4 Respiratory Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Respiratory Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Respiratory Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Respiratory Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Respiratory Drug Sales by Product
    • 4.2 Global Respiratory Drug Revenue by Product
    • 4.3 Respiratory Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Respiratory Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Respiratory Drug by Countries
      • 6.1.1 North America Respiratory Drug Sales by Countries
      • 6.1.2 North America Respiratory Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Respiratory Drug by Product
    • 6.3 North America Respiratory Drug by End User

    7 Europe

    • 7.1 Europe Respiratory Drug by Countries
      • 7.1.1 Europe Respiratory Drug Sales by Countries
      • 7.1.2 Europe Respiratory Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Respiratory Drug by Product
    • 7.3 Europe Respiratory Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Respiratory Drug by Countries
      • 8.1.1 Asia Pacific Respiratory Drug Sales by Countries
      • 8.1.2 Asia Pacific Respiratory Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Respiratory Drug by Product
    • 8.3 Asia Pacific Respiratory Drug by End User

    9 Central & South America

    • 9.1 Central & South America Respiratory Drug by Countries
      • 9.1.1 Central & South America Respiratory Drug Sales by Countries
      • 9.1.2 Central & South America Respiratory Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Respiratory Drug by Product
    • 9.3 Central & South America Respiratory Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Respiratory Drug by Countries
      • 10.1.1 Middle East and Africa Respiratory Drug Sales by Countries
      • 10.1.2 Middle East and Africa Respiratory Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Respiratory Drug by Product
    • 10.3 Middle East and Africa Respiratory Drug by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Respiratory Drug Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Boehringer Ingelheim
      • 11.2.1 Boehringer Ingelheim Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boehringer Ingelheim Respiratory Drug Products Offered
      • 11.2.5 Boehringer Ingelheim Recent Development
    • 11.3 AstraZeneca
      • 11.3.1 AstraZeneca Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 AstraZeneca Respiratory Drug Products Offered
      • 11.3.5 AstraZeneca Recent Development
    • 11.4 Merck
      • 11.4.1 Merck Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck Respiratory Drug Products Offered
      • 11.4.5 Merck Recent Development
    • 11.5 Novartis
      • 11.5.1 Novartis Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Novartis Respiratory Drug Products Offered
      • 11.5.5 Novartis Recent Development
    • 11.6 Omron
      • 11.6.1 Omron Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Omron Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Omron Respiratory Drug Products Offered
      • 11.6.5 Omron Recent Development
    • 11.7 Sunovion
      • 11.7.1 Sunovion Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Sunovion Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Sunovion Respiratory Drug Products Offered
      • 11.7.5 Sunovion Recent Development
    • 11.8 Air Liquide
      • 11.8.1 Air Liquide Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Air Liquide Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Air Liquide Respiratory Drug Products Offered
      • 11.8.5 Air Liquide Recent Development
    • 11.9 Aradigm
      • 11.9.1 Aradigm Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Aradigm Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Aradigm Respiratory Drug Products Offered
      • 11.9.5 Aradigm Recent Development
    • 11.10 Baxter
      • 11.10.1 Baxter Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Baxter Respiratory Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Baxter Respiratory Drug Products Offered
      • 11.10.5 Baxter Recent Development
    • 11.11 Beximco Pharmaceuticals
    • 11.12 Compumedics
    • 11.13 Pfizer
    • 11.14 Draeger
    • 11.15 Roche
    • 11.16 Fisher & Paykel Healthcare
    • 11.17 GE Healthcare
    • 11.18 Genentech
    • 11.19 Grifols
    • 11.20 Hamilton Medical

    12 Future Forecast

    • 12.1 Respiratory Drug Market Forecast by Regions
      • 12.1.1 Global Respiratory Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Respiratory Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Respiratory Drug Market Forecast by Product
      • 12.2.1 Global Respiratory Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Respiratory Drug Revenue Forecast by Product 2019-2025
    • 12.3 Respiratory Drug Market Forecast by End User
    • 12.4 North America Respiratory Drug Forecast
    • 12.5 Europe Respiratory Drug Forecast
    • 12.6 Asia Pacific Respiratory Drug Forecast
    • 12.7 Central & South America Respiratory Drug Forecast
    • 12.8 Middle East and Africa Respiratory Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Respiratory Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Drug used for respiratory disease.
      Major factors contributing to the growth of the global respiratory drug market include increasing prevalence of chronic respiratory diseases such as asthma and COPD.
      The global Respiratory Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Respiratory Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Respiratory Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Respiratory Drug in these regions.
      This research report categorizes the global Respiratory Drug market by top players/brands, region, type and end user. This report also studies the global Respiratory Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GSK
      Boehringer Ingelheim
      AstraZeneca
      Merck
      Novartis
      Omron
      Sunovion
      Air Liquide
      Aradigm
      Baxter
      Beximco Pharmaceuticals
      Compumedics
      Pfizer
      Draeger
      Roche
      Fisher & Paykel Healthcare
      GE Healthcare
      Genentech
      Grifols
      Hamilton Medical

      Market size by Product
      Advair
      Symbicort turbuhaler
      Spiriva
      Xolair
      Ventolin
      Pulmicort
      Orkambi
      Relvar/breo ellipta
      Singulair
      Esbriet
      Market size by End User
      Hospitals
      Home care

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Respiratory Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Respiratory Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Respiratory Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Respiratory Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Respiratory Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Respiratory Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Respiratory Drug . Industry analysis & Market Report on Respiratory Drug is a syndicated market report, published as Global Respiratory Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Respiratory Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,117.69
      4,676.54
      6,235.38
      3,472.34
      5,208.51
      6,944.68
      420,030.00
      630,045.00
      840,060.00
      268,557.90
      402,836.85
      537,115.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report